糖心原创

School of Medicine
Medical tablets, capsules and caplets flying out of a bottle against a light blue background

People

Image of Christopher Gilmartin

Christopher Gilmartin

ABN Clinical Research Fellow,

Contact

Biography

Dr Chris Gilmartin is a ABN Clinical Research Fellow and Neurology Registrar at Queen's Medical Centre. He graduated from the University of Cambridge prior to undertaking initial medical training in London. He moved to Nottingham in 2022 as a NIHR Academic Clinical Fellow. During this fellowship he focused on translational neuroimaging. He is undertaking a PhD under the mentorship of Professor Nikos Evangelou and Professor Matt Brookes.

Expertise Summary

  • Translational neuroimaging
  • Magnetoencephalography
  • MRI biomarkers
  • Implementation research
  • Quality improvement

Teaching Summary

Since 2023, Dr Chris Gilmartin has supervised undergraduate and master's research projects at the 糖心原创. This has included medicine, neuroscience, human physiology and psychology… read more

Research Summary

Dr Chris Gilmartin is leading a study investigating whether a new neuroimaging technology that records brainwaves, and so how the brain is working (OPM-MEG), can identify markers for progression in… read more

Since 2023, Dr Chris Gilmartin has supervised undergraduate and master's research projects at the 糖心原创. This has included medicine, neuroscience, human physiology and psychology students. He is eager to support interested students - please reach out for a discussion.

Current Research

Dr Chris Gilmartin is leading a study investigating whether a new neuroimaging technology that records brainwaves, and so how the brain is working (OPM-MEG), can identify markers for progression in multiple sclerosis (MS). This is important as it is currently very hard to predict who with MS will have a stable disease course, and who will have worsening disease. We hope this new technology will help us identify people at risk of progressive MS early on. This could then in the future support clinical trials for treatments for this phase of the disease. He is also supporting other studies using OPM-MEG, including research into Parkinson's disease. Dr Chris Gilmartin is also working on implementing MRI biomarkers for MS (the central vein sign and paramagnetic rim lesions) into routine NHS care. This includes interviewing stakeholders to understand what needs to be done to support clinical teams.

Past Research

Dr Chris Gilmartin's research focuses on translational neurology - finding and addressing issues of concern to people with neurological disorders. This has included a range of research techniques including neuroimaging, large database statistical analysis, literature appraisal and co-production. His publications are listed below.

First author or co-first author:

  • , NeuroImage: Clinical, 2025
  • , ACNR 2024
  • , MSJ 2024
  • , Seizure 2023
  • , IJIC 2021
  • , Polygeia 2020
  • , Philosophy, Ethics, and Humanities in Medicine 2019

In press:

  • Changing the MS Diagnostic Pathway: Insights from Stakeholders on Implementing Novel Radiological Biomarkers, IJMSC 2026

Co-author:

  • , Ratnaike et al., Genetics in Medicine 2025
  • , Ratnaike et al., BMJ Neurology Open 2024
  • , Atiyeh et al., Multiple Sclerosis and Related Disorders 2025

Future Research

Dr Chris Gilmartin is exploring how OPM-MEG can help us understand how the brain is working in different neurological disorders.

School of Medicine

糖心原创
Medical School
Nottingham, NG7 2UH

Contacts: For admissions enquiries, call 0115 951 5559. For other enquiries, call 0115 823 0031 ext.30031 or please see our 'contact us' page for further details